Nesiritide (Natrecor) is the recombinant form of the 32 amino acid human B-type
natriuretic peptide, which is normally produced by the ventricular myocardium.
Easy to read patient leaflet for nesiritide. Includes indications, proper use, special
instructions, precautions, and possible side effects.
Nesiritide, a recombinant human B-type natriuretic peptide, is the first in a new
drug class for the treatment of decompensated heart failure. The drug binds to ...
Nesiritide (Natrecor) is a recombinant form of human B-type (brain) natriuretic
peptide that has beneficial vasodilatory, natriuretic, diuretic and neurohormonal ...
Medscape - Indication-specific dosing for Natrecor (nesiritide), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
Feb 15, 2006 ... Nesiritide improves short-term hemodynamics in hospitalized patients with acute
decompensated heart failure who have not benefited from ...
Jun 13, 2016 ... Acute decompensated heart failure (HF) is a common and potentially fatal cause
of acute respiratory distress. The clinical syndrome is ...
Drug information on Natrecor (nesiritide), includes drug pictures, side effects,
drug interactions, directions for use, symptoms of overdose, and what to avoid.
Sep 1, 2015 ... Nesiritide is used for patients who have severe congestive heart failure that has
recently become worse. Nesiritide is for patients who are short ...
Oct 21, 2007 ... Nesiritide is the recombinant form of the 32 amino acid human B-type natriuretic
peptide, which is normally produced by the ventricular ...